TxCell CEO says acquisition by Sangamo a ‘perfect fit’ 25-Jul-2018 By Ben Hargreaves TxCell confirmed that it has accepted a €72m offer from Sangamo in a deal that will be completed by the end of the year.
TxCell snaps up option to in-license CAR-Treg programme 10-Jul-2018 By Ben Hargreaves TxCell has announced that it has exercised its option to in-license a HLA-A2 CAR-Treg programme from its partner, the University of British Columbia.